Detalles de la búsqueda
1.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Breast Cancer Res Treat
; 189(2): 455-461, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131830
2.
Development of a Low-Resource Operating Room and a Wide-Awake Orthopedic Surgery Program During the COVID-19 Pandemic.
Surg Innov
; 28(2): 183-188, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780646
3.
Outcomes of Nipple-sparing Mastectomy with Reconstruction after Recent Oncoplastic Wise-pattern Reduction.
Plast Reconstr Surg Glob Open
; 11(1): e4731, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36699213
4.
OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated Study.
Hematol Oncol Stem Cell Ther
; 16(4): 412-419, 2023 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363979
5.
Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers: An Opportunity to Eliminate Overtreatment and Decrease Testing Costs.
Hematol Oncol Stem Cell Ther
; 15(1): 44-51, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34174200
Resultados
1 -
5
de 5
1
Próxima >
>>